Loss of COP1 expression determines poor prognosisin patients with gastric cancer.

Previous studies have suggested conflicting roles for the E3 ubiquitin ligase COP1 in tumorigenesis, providing evidence that both the oncoprotein c-Jun and the tumor suppressor p53 may be COP1 targets. In the present study, we focused on the clinical significance of COP1 expression in gastric cancer cases and analyzed the malignant behavior of COP1‑knockdown gastric cancer cells in vitro. We analyzed COP1 expression in cancer lesions and the corresponding normal mucosa to demonstrate the clinical significance of COP1 expression in 133 cases of gastric cancer. We also investigated the relationship between COP1 expression and cell proliferation and the association of COP1 with c‑Jun transcriptional target genes, such as MMP1, MMP7 and MMP10. The expression of COP1 mRNA was significantly lower in gastric cancer tissues compared to the corresponding normal mucosa (P=0.049). In multivariate analysis for overall survival, we found that COP1 expression was an independent prognostic factor in gastric cancer. Knockdown of COP1 expression in the gastric cancer cell lines MKN‑45 and NUGC4 promoted proliferation, and significant associations between COP1 expression and MMP1, MMP7 and MMP10 were also observed in knockdown assays. In conclusion, the present study suggests that loss of COP1 expression may be a novel indicator for the biological aggressiveness in gastric cancer.

[1]  Chun-yu Huang,et al.  High Level of COP1 Expression is Associated with Poor Prognosis in Primary Gastric Cancer , 2012, International journal of biological sciences.

[2]  J. Marine.  Spotlight on the role of COP1 in tumorigenesis , 2012, Nature Reviews Cancer.

[3]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[4]  S. Oh.  Update of Adjuvant Chemotherapy for Resected Gastric Cancer , 2012, Journal of gastric cancer.

[5]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[6]  K. Leong,et al.  COP1 is a tumour suppressor that causes degradation of ETS transcription factors , 2011, Nature.

[7]  S. Bogaerts,et al.  Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. , 2011, The Journal of clinical investigation.

[8]  S. Thorgeirsson,et al.  Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. , 2010, Cancer research.

[9]  Da-Qiang Li,et al.  E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1 , 2009, Proceedings of the National Academy of Sciences.

[10]  R. Deshaies,et al.  RING domain E3 ubiquitin ligases. , 2009, Annual review of biochemistry.

[11]  B. Xiao,et al.  Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.

[12]  J. Xiang,et al.  Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer , 2009, The British journal of surgery.

[13]  R. Pardi,et al.  COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1 , 2008, Oncogene.

[14]  Somasekar Seshagiri,et al.  ATM Engages Autodegradation of the E3 Ubiquitin Ligase COP1 After DNA Damage , 2006, Science.

[15]  G. Frantz,et al.  COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas , 2004, Cancer Research.

[16]  Patrick Dowd,et al.  The ubiquitin ligase COP1 is a critical negative regulator of p53 , 2004, Nature.

[17]  R. Deshaies,et al.  Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase , 2004, Science.

[18]  R. Pardi,et al.  Characterization of Human Constitutive Photomorphogenesis Protein 1, a RING Finger Ubiquitin Ligase That Interacts with Jun Transcription Factors and Modulates Their Transcriptional Activity* , 2003, Journal of Biological Chemistry.

[19]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[20]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[21]  J. R. Kelley,et al.  Gastric cancer epidemiology and risk factors. , 2003, Journal of clinical epidemiology.